Early vs. Late Chemoradiation Therapy and the Postoperative Interval to Adjuvant Therapy Do Not Correspond to Local Recurrence in Resected Pancreatic Cancer

Pancreatic Disorders & Therapy
doi 10.4172/2165-7092.1000151
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group

Related search

Role of Adjuvant Therapy in Resected Stage IA Subcentimeter (T1a/T1b) Pancreatic Cancer

Cancer
Cancer ResearchOncology
2018English

Longer Times on Adjuvant Endocrine Therapy Correspond to Improved Functional Capacity and Lower Adiposity in Women on Adjuvant Therapy

Clinical Breast Cancer
Cancer ResearchOncology
2019English

Do We Have Enough Evidence for Adjuvant Postoperative Chemoradiation in Esophageal Cancer?

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2017English

Utilization of Intravascular Ultrasound to Assess Vascular Invasion in Pancreatic Cancer Post Chemoradiation Therapy

Journal of Vascular Medicine & Surgery
2016English

Comparison of Perioperative Chemotherapy and Adjuvant Chemoradiation in Resected Gastric Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2015English

Interval Between Breast-Conserving Surgery and Start of Radiation Therapy in Early-Stage Breast Cancer Is Not Predictive of Local Recurrence: A Single-Institution Experience

Clinical Breast Cancer
Cancer ResearchOncology
2011English

Current Status of Adjuvant Therapy for Pancreatic Cancer

Oncologist
Cancer ResearchMedicineOncology
2010English

Adjuvant Chemoradiation for Resected Gastric Cancer: A 10-Year Experience

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2011English

Adjuvant Endocrine Therapy in Early Postmenopausal Breast Cancer

Breast Care
SurgeryOncology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy